November 25, 2014
The Ministry of Health, Labor and Welfare (MHLW) has designated six active pharmaceutical ingredients (APIs) as orphan drugs, including Alexion Pharma’s recombinant eculizumab. Eculizumab was granted the designation for the relapse prevention of NMO-IgG-positive relapsing neuromyelitis optica (NMO). The five...read more